Pancreatic Cancer Research

ResearcherMasaryk UniversityActive in the last 2 years

Vladimír Procházka

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7747-6072; OpenAlex author ID A5020562392, A5023904192. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 3 papers

Papers 9

  1. Ex-Vivo 3D Cellular Models of Pancreatic Ductal Adenocarcinoma: From Embryonic Development to Precision Oncology. Co-author DOI 10.1097/mpa.0000000000002393↗
  2. Artificial intelligence in pancreatic cancer histopathology and diagnostics - implications for clinical decisions and biomarker discovery? Co-author DOI 10.1186/s13008-025-00158-w↗
  3. Integrated clinical-bio logical infrastructure for precision oncology in pancreatic adenocarcinoma - experience with REDCap implementation in an academic setti… Co-author DOI 10.48095/ccko2025464↗
  4. Minimal invasive surgery of pancreatic cancer at the Department of Surgery of Masaryk university hospital Brno, Czech Republic. Co-author DOI 10.33699/pis.2024.103.4.122-131↗
  5. Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection. Co-author DOI 10.3390/jcm9082440↗
  6. Cell-free microRNAs as Non-invasive Diagnostic and Prognostic Bio- markers in Pancreatic Cancer. First author DOI 10.2174/1389202921666191217095017↗
  7. Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical… Last author DOI 10.21873/cgp.20090↗
  8. MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13000-015-0272-6↗
  9. Is physical activity a protective factor against pancreatic cancer? Co-author DOI 10.4149/bll_2014_091↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jan Hlavsa · 7 shared papers, 2015–2025 · strength 1.12
  2. Petr Moravčík · 4 shared papers, 2024–2025 · strength 0.90
  3. Michal Eid · 4 shared papers, 2024–2025 · strength 0.90
  4. Zdeněk Kala · 6 shared papers, 2015–2025 · strength 0.79
  5. Petr Vaňhara · 3 shared papers, 2025 · strength 0.72
  6. Petra Weselá · 2 shared papers, 2025 · strength 0.51
  7. Ivana Aćimović · 2 shared papers, 2025 · strength 0.45
  8. Ondřej Slabý · 4 shared papers, 2015–2020 · strength 0.35
  9. Igor Kišš · 4 shared papers, 2015–2020 · strength 0.35
  10. Natalia Gabło · 3 shared papers, 2018–2020 · strength 0.31
  11. Ján Trnka · 1 shared paper, 2025 · strength 0.22
  12. Stanislava Martínková · 1 shared paper, 2025 · strength 0.22
  13. Markéta Hermanová · 2 shared papers, 2015–2018 · strength 0.12
  14. Petra Vychytilova‐Faltejskova · 2 shared papers, 2015–2018 · strength 0.12
  15. Petr Karásek · 2 shared papers, 2015–2018 · strength 0.12
  16. Martin Loveček · 1 shared paper, 2020 · strength 0.10
  17. Ioana Berindan‐Neagoe · 1 shared paper, 2020 · strength 0.10
  18. Jiří Lenz · 1 shared paper, 2015 · strength 0.04
  19. Kateřina Azeem · 1 shared paper, 2014 · strength 0.04
  20. Helena Kollárová · 1 shared paper, 2014 · strength 0.04
  21. Arnošt Martínek · 1 shared paper, 2014 · strength 0.04
  22. Vladimí­r Janout · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.